Categories Earnings, Health Care

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit.

  • Revenues increased 13% year-over-year to $53.5 billion in the final three months of fiscal 2023
  • Fourth-quarter operating earnings came in at $137 million, sharply higher than the $36 million reported a year earlier
  • The company reported a net loss of $64 million or $0.25 per share for Q4, compared to a profit of $138 million or $0.50 per share last year
  • On an adjusted basis, it was a profit of $1.55 per share, compared to $1.05 per share in the same quarter of 2022
  • The Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit rose to $82 million
  • The company generated both operating cash flow and adjusted free cash flow of $2.8 billion in Q4
  • The management raised its fiscal 2024 adjusted EPS guidance to the range of $6.50 to $6.75, from $6.45-$6.70

Most Popular

Important takeaways from Conagra Brands’ Q4 2025 report

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported weaker-than-expected sales and adjusted earnings for its fourth quarter, reflecting ongoing economic uncertainty and muted consumer spending.

Delta Air Lines (DAL) gains on strong Q2 2025 performance

Shares of Delta Air Lines (NYSE: DAL) rose 12% on Thursday after the company delivered strong results for the second quarter of 2025 and restored its guidance for the full

CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top